These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12039429)

  • 21. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
    Okada Y; Murata M; Toda T
    Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Unified Parkinson's Disease Rating Scale and the Short Parkinson's Evaluation Scale in patients with Parkinson's disease after levodopa loading.
    Rabey JM; Klein C; Molochnikov A; Van Hilten B; Krauss P; Bonuccelli U
    Clin Neuropharmacol; 2002; 25(2):83-8. PubMed ID: 11981234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
    Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
    Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of motor symptoms in Parkinson's disease].
    Morís-De la Tassa G; Arias-Rodríguez M
    Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic influences on the P300 abnormality in Parkinson's disease.
    Sohn YH; Kim GW; Huh K; Kim JS
    J Neurol Sci; 1998 Jun; 158(1):83-7. PubMed ID: 9667783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device.
    Nombela C; Pedreño-Molina JL; Ros-Bernal F; Molina-Vilaplana J; Fdez-Villalba E; López-Coronado J; Herrero MT
    Hum Mov Sci; 2012 Jun; 31(3):730-42. PubMed ID: 22414696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
    Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F
    Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
    Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levodopa improves handwriting and instrumental tasks in previously treated patients with Parkinson's disease.
    Müller T; Harati A
    J Neural Transm (Vienna); 2020 Oct; 127(10):1369-1376. PubMed ID: 32813086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
    Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
    Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levodopa increases speed of alternating movements in Parkinson's disease patients.
    Müller T; Peters S; Harati A
    J Neural Transm (Vienna); 2013 Feb; 120(2):309-13. PubMed ID: 22722446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.
    Teo WP; Rodrigues JP; Mastaglia FL; Thickbroom GW
    Clin Neurophysiol; 2014 Mar; 125(3):562-8. PubMed ID: 24095151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current possibilities of quality of life improvement in the late stages of Parkinson's disease].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):94-100. PubMed ID: 26171484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
    Kuhn W; Müller T; Winkel R; Danielczik S; Gerstner A; Häcker R; Mattern C; Przuntek H
    J Neural Transm (Vienna); 1996; 103(10):1187-93. PubMed ID: 9013405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
    Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J;
    Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.